Gozde Kavgaci
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country.
Journal: Expert review of anticancer therapy
Published: July 04, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors.
Journal: Expert review of molecular diagnostics
Published: February 26, 2025
Evaluating Immunotherapy Responses in Neuro-Oncology for Glioblastoma and Brain Metastases: A Brief Review Featuring Three Cases.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: February 15, 2025
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive review.
Journal: Cancer treatment reviews
Published: February 10, 2025
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancer.
Journal: Expert review of anticancer therapy
Published: December 14, 2024
Ribociclib-induced autoimmune-like hepatitis: a case report.
Journal: Journal of chemotherapy (Florence, Italy)
Published: November 29, 2024
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: September 03, 2024
Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes.
Journal: Molecular and clinical oncology
Published: August 22, 2024
The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer.
Journal: Medicine
Published: July 26, 2024
Last Updated: 09/26/2026